Overview

TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)

Status:
Terminated
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
This study aims to assess the role of MET inhibitors as maintenance treatment in adult patients with extensive stage small cell lung cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Istituto Oncologico Veneto IRCCS